Vectus Biosystems Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Stock Symbol
  • VBS

Stock Symbol

  • Share Price
  • $0.03
  • (As of Tuesday Closing)

Vectus Biosystems General Information

Description

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including cardio, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Unit 5, Ground Floor
  • 26-34 Dunning Avenue
  • Rosebery, New South Wales 2018
  • Australia
+61 (02)
Primary Industry
Drug Discovery
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • Unit 5, Ground Floor
  • 26-34 Dunning Avenue
  • Rosebery, New South Wales 2018
  • Australia
+61 (02)

Vectus Biosystems Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vectus Biosystems Stock Performance

As of 17-Nov-2026, Vectus Biosystems’s stock price is $0.03. Its current market cap is $2.09M with 62.2M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.04 $0.03 - $0.15 $2.09M 62.2M 52.8K

Vectus Biosystems Financials Summary

As of 30-Sep-2026, Vectus Biosystems has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 2,705 5,401 863 1,382
EBITDA 1,084 (1,151) (1,538)
Net Income 1,056 (1,150) (1,532)
Total Assets 2,627 511 1,354
Total Debt 376 131 19
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vectus Biosystems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vectus Biosystems‘s full profile, request access.

Request a free trial

Vectus Biosystems Patents

Vectus Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016903799-A0 Compositions for the treatment of hypertension and/or fibrosis Inactive 21-Sep-2016
AU-2016903804-A0 Compositions for the treatment of hypertension and/or fibrosis Inactive 21-Sep-2016
AU-2017329111-A1 Compositions for the treatment of hypertension and/or fibrosis Active 21-Sep-2016
AU-2017329111-B2 Compositions for the treatment of hypertension and/or fibrosis Active 21-Sep-2016
AU-2017329111-B9 Compositions for the treatment of hypertension and/or fibrosis Active 21-Sep-2016 C07D233/64
To view Vectus Biosystems’s complete patent history, request access »

Vectus Biosystems ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Vectus Biosystems’s complete esg history, request access »

Vectus Biosystems FAQs

  • When was Vectus Biosystems founded?

    Vectus Biosystems was founded in 2005.

  • Where is Vectus Biosystems headquartered?

    Vectus Biosystems is headquartered in Rosebery, Australia.

  • What industry is Vectus Biosystems in?

    Vectus Biosystems’s primary industry is Drug Discovery.

  • Is Vectus Biosystems a private or public company?

    Vectus Biosystems is a Public company.

  • What is Vectus Biosystems’s stock symbol?

    The ticker symbol for Vectus Biosystems is VBS.

  • What is the current stock price of Vectus Biosystems?

    As of 17-Nov-2026 the stock price of Vectus Biosystems is $0.03.

  • What is the current market cap of Vectus Biosystems?

    The current market capitalization of Vectus Biosystems is $2.09M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process